AAAAAA

   
Results: 1-23 |
Results: 23
HIV HYPERIMMUNE GLOBULIN OR INTRAVENOUS IMMUNE GLOBULIN INHIBITS RESPONSE TO AN HIV VACCINE
Authors: JELONEK MT MASKREY JL CUMMINS LM ARORA Y STEIMER KS WHITESCHARF M KELLER MA
Citation: Mt. Jelonek et al., HIV HYPERIMMUNE GLOBULIN OR INTRAVENOUS IMMUNE GLOBULIN INHIBITS RESPONSE TO AN HIV VACCINE, Biotechnology and applied biochemistry, 27, 1998, pp. 89-95
HIV-GP120 INDUCED CELL-DEATH IN HEMATOPOIETIC PROGENITOR CD34(+) CELLS
Authors: BANDA NK TOMCZAK JA SHPALL EJ SIPPLE J AKKINA RK STEIMER KS HAMI L CURIEL TJ HARRISON GS
Citation: Nk. Banda et al., HIV-GP120 INDUCED CELL-DEATH IN HEMATOPOIETIC PROGENITOR CD34(+) CELLS, Apoptosis, 2(1), 1997, pp. 61-68
VACCINATION WITH HIV-1 GP120 DNA INDUCES IMMUNE-RESPONSES THAT ARE BOOSTED BY A RECOMBINANT GP120 PROTEIN SUBUNIT
Authors: BARNETT SW RAJASEKAR S LEGG H DOE B FULLER DH HAYNES JR WALKER CM STEIMER KS
Citation: Sw. Barnett et al., VACCINATION WITH HIV-1 GP120 DNA INDUCES IMMUNE-RESPONSES THAT ARE BOOSTED BY A RECOMBINANT GP120 PROTEIN SUBUNIT, Vaccine, 15(8), 1997, pp. 869-873
INHIBITION OF ANTI-V3 LOOP RESPONSE TO RGP120(SF2) VACCINE BY PREEXISTING MONOCLONAL-ANTIBODY
Authors: KELLER MA ARORA Y MASKREY J STEIMER KS
Citation: Ma. Keller et al., INHIBITION OF ANTI-V3 LOOP RESPONSE TO RGP120(SF2) VACCINE BY PREEXISTING MONOCLONAL-ANTIBODY, Journal of allergy and clinical immunology, 99(1), 1997, pp. 1164-1164
EXPRESSION OF CD69 AFTER IN-VITRO STIMULATION - A RAPID METHOD FOR QUANTITATING IMPAIRED LYMPHOCYTE-RESPONSES IN HIV-INFECTED INDIVIDUALS
Authors: KROWKA JF CUEVAS B MARON DC STEIMER KS ASCHER MS SHEPPARD HW
Citation: Jf. Krowka et al., EXPRESSION OF CD69 AFTER IN-VITRO STIMULATION - A RAPID METHOD FOR QUANTITATING IMPAIRED LYMPHOCYTE-RESPONSES IN HIV-INFECTED INDIVIDUALS, Journal of acquired immune deficiency syndromes and human retrovirology, 11(1), 1996, pp. 95-104
TITRATION OF A VACCINE STOCK PREPARATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1(SF2) IN CULTURED LYMPHOCYTES AND IN CHIMPANZEES
Authors: MURTHY KK COBB EK ELAMAD Z ORTEGA H HSUEH FC SATTERFIELD W LEE DR KALISH ML HAIGWOOD NL KENNEDY RC STEIMER KS SCHULTZ A LEVY JA
Citation: Kk. Murthy et al., TITRATION OF A VACCINE STOCK PREPARATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1(SF2) IN CULTURED LYMPHOCYTES AND IN CHIMPANZEES, AIDS research and human retroviruses, 12(14), 1996, pp. 1341-1348
MATERNAL MONOCLONAL-ANTIBODY TO THE V3 LOOP ALTERS SPECIFICITY OF THERESPONSE TO A HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE
Authors: JELONEK MT MASKREY JL STEIMER KS POTTS BJ HIGGINS KW KELLER MA
Citation: Mt. Jelonek et al., MATERNAL MONOCLONAL-ANTIBODY TO THE V3 LOOP ALTERS SPECIFICITY OF THERESPONSE TO A HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE, The Journal of infectious diseases, 174(4), 1996, pp. 866-869
HIV VACCINES - THE NEXT-GENERATION
Authors: BARNETT SW KLINGER J RAJASEKAR S LEGG H DOE B SELBY M WALKER CM STEIMER KS
Citation: Sw. Barnett et al., HIV VACCINES - THE NEXT-GENERATION, AIDS research and human retroviruses, 11, 1995, pp. 135-135
RESISTANCE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT GP120(SF2) TO CHALLENGE BY HIV-1(SF2)
Authors: ELAMAD Z MURTHY KK HIGGINS K COBB EK HAIGWOOD NL LEVY JA STEIMER KS
Citation: Z. Elamad et al., RESISTANCE OF CHIMPANZEES IMMUNIZED WITH RECOMBINANT GP120(SF2) TO CHALLENGE BY HIV-1(SF2), AIDS, 9(12), 1995, pp. 1313-1322
SUMMARY OF THE WORKSHOP ON PASSIVE IMMUNOTHERAPY IN THE PREVENTION AND TREATMENT OF HIV-INFECTION
Authors: STIEHM ER MOFENSON L ZOLLAPAZNER S JACKSON B MARTIN NL AMMANN AJ AMMANN A ANDRUS L BURTON D COOMBS RW CUMMINS L DULIEGE AM FAST P FOWLER MG GOLDENTHAL K KOENIG S KOUP R MADDON P MARTIN N MATHIESON B MEYER WA NEMO G POTTS B ROSSI P PRINCE A STEIMER KS
Citation: Er. Stiehm et al., SUMMARY OF THE WORKSHOP ON PASSIVE IMMUNOTHERAPY IN THE PREVENTION AND TREATMENT OF HIV-INFECTION, Clinical immunology and immunopathology, 75(1), 1995, pp. 84-93
INHIBITION OF THE OFFSPRING ANTI-RECOMBINANT GP120 ANTIBODY-RESPONSE TO A HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE BY MATERNAL IMMUNIZATION IN A MURINE MODEL
Authors: JELONEK MT MASKREY JL STEIMER KS POTTS BJ HIGGINS KW KELLER MA
Citation: Mt. Jelonek et al., INHIBITION OF THE OFFSPRING ANTI-RECOMBINANT GP120 ANTIBODY-RESPONSE TO A HUMAN-IMMUNODEFICIENCY-VIRUS VACCINE BY MATERNAL IMMUNIZATION IN A MURINE MODEL, The Journal of infectious diseases, 172(2), 1995, pp. 539-542
CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL OBSERVATIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-I INFECTION IN A VOLUNTEER IN AN HIV-1 VACCINE CLINICAL-TRIAL
Authors: KAHN JO STEIMER KS BAENZIGER J DULIEGE AM FEINBERG M ELBEIK T CHESNEY M MURCAR N CHERNOFF D SINANGIL F
Citation: Jo. Kahn et al., CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL OBSERVATIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-I INFECTION IN A VOLUNTEER IN AN HIV-1 VACCINE CLINICAL-TRIAL, The Journal of infectious diseases, 171(5), 1995, pp. 1343-1347
PRIMARY ISOLATE NEUTRALIZING ACTIVITY OF HUMAN-ANTIBODIES DIRECTED TORECOMBINANT, NATIVE HIV-SF2 GP120 (RGP120(SF2))
Authors: STEIMER KS SINANGIL F KAHN J CHERNOFF D DULIEGE AM BAENZIGER J
Citation: Ks. Steimer et al., PRIMARY ISOLATE NEUTRALIZING ACTIVITY OF HUMAN-ANTIBODIES DIRECTED TORECOMBINANT, NATIVE HIV-SF2 GP120 (RGP120(SF2)), AIDS research and human retroviruses, 10, 1994, pp. 190000055-190000055
ONE-YEAR FOLLOW-UP OF A PHASE-1 STUDY OF HIV-1 GP120 VACCINE COMBINEDWITH MF59 AND WITH A DOSE-ESCALATION OF MTP-PE IN HIV-1 NONINFECTED ADULTS
Authors: KAHN J CHERNOFF D SINANGIL F BAENZIGER J MURCAR N COLEMAN R WYNNE D LEE D HESTERMAN K SAKAMOTO D CUISON G DEKKER C STEIMER KS
Citation: J. Kahn et al., ONE-YEAR FOLLOW-UP OF A PHASE-1 STUDY OF HIV-1 GP120 VACCINE COMBINEDWITH MF59 AND WITH A DOSE-ESCALATION OF MTP-PE IN HIV-1 NONINFECTED ADULTS, AIDS research and human retroviruses, 10, 1994, pp. 190000155-190000155
MAPPING OF B-CELL AND T-CELL RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120
Authors: STEIMER KS SINANGIL F BAENZIGER J KAHN J DINA D
Citation: Ks. Steimer et al., MAPPING OF B-CELL AND T-CELL RESPONSES OF HIV-1 SERONEGATIVE INDIVIDUALS VACCINATED WITH RECOMBINANT HIV-SF2 GP120, AIDS research and human retroviruses, 10, 1994, pp. 190000047-190000047
EPITOPES RECOGNIZED BY HIV-SF2 NEF-SPECIFIC CD4-CELL CLONES GENERATEDFROM HIV-1-UNINFECTED DONORS( T)
Authors: WENTWORTH PA BATHURST I FEUCHT PH ERLICH HA STEIMER KS
Citation: Pa. Wentworth et al., EPITOPES RECOGNIZED BY HIV-SF2 NEF-SPECIFIC CD4-CELL CLONES GENERATEDFROM HIV-1-UNINFECTED DONORS( T), Vaccine, 12(2), 1994, pp. 117-128
CHARACTERIZATION OF HUMAN CD4-SF2 NEF-SPECIFIC T-CELL CLONES FOR ANTIGEN-PROCESSING AND PRESENTATION REQUIREMENTS AND FOR CYTOTOXIC ACTIVITY(, HIV)
Authors: WENTWORTH PA STEIMER KS
Citation: Pa. Wentworth et Ks. Steimer, CHARACTERIZATION OF HUMAN CD4-SF2 NEF-SPECIFIC T-CELL CLONES FOR ANTIGEN-PROCESSING AND PRESENTATION REQUIREMENTS AND FOR CYTOTOXIC ACTIVITY(, HIV), Vaccine, 12(10), 1994, pp. 885-894
CLINICAL AND IMMUNOLOGICAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE 1(SF2) GP120 SUBUNIT VACCINE COMBINED WITH MF59 ADJUVANT WITH OR WITHOUT MURAMYL TRIPEPTIDE DIPALMITOYL PHOSPHATIDYLETHANOLAMINE IN NON-HIV-INFECTED HUMAN VOLUNTEERS
Authors: KAHN JO SINANGIL F BAENZIGER J MURCAR N WYNNE D COLEMAN RL STEIMER KS DEKKER CL CHERNOFF D
Citation: Jo. Kahn et al., CLINICAL AND IMMUNOLOGICAL RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE 1(SF2) GP120 SUBUNIT VACCINE COMBINED WITH MF59 ADJUVANT WITH OR WITHOUT MURAMYL TRIPEPTIDE DIPALMITOYL PHOSPHATIDYLETHANOLAMINE IN NON-HIV-INFECTED HUMAN VOLUNTEERS, The Journal of infectious diseases, 170(5), 1994, pp. 1288-1291
INDUCTION OF HIV-1 ENVELOPE (GP120)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN MICE BY RECOMBINANT CHO CELL-DERIVED GP120 IS ENHANCED BY ENZYMATIC REMOVAL OF N-LINKED GLYCANS
Authors: DOE B STEIMER KS WALKER CM
Citation: B. Doe et al., INDUCTION OF HIV-1 ENVELOPE (GP120)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES IN MICE BY RECOMBINANT CHO CELL-DERIVED GP120 IS ENHANCED BY ENZYMATIC REMOVAL OF N-LINKED GLYCANS, European Journal of Immunology, 24(10), 1994, pp. 2369-2376
NEUTRALIZATION OF PRIMARY HIV-1 ISOLATES BY SERA FROM PRIMATES IMMUNIZED WITH RECOMBINANT HIV-SF2 GP120
Authors: STEIMER KS YOSHIYAMA H MCCLURE J HO DD SCANDELLA CJ HAIGWOOD NL
Citation: Ks. Steimer et al., NEUTRALIZATION OF PRIMARY HIV-1 ISOLATES BY SERA FROM PRIMATES IMMUNIZED WITH RECOMBINANT HIV-SF2 GP120, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 684-684
CHARACTERIZATION OF GROUP-SPECIFIC ANTIBODIES GENERATED BY LENTIVIRUSINFECTION OR SUBUNIT IMMUNIZATION IN PRIMATES
Authors: HAIGWOOD NL ELAMAD Z CHIN SM STEIMER KS JENNINGS M GARDNER M HIRSCH VM JOHNSON PR
Citation: Nl. Haigwood et al., CHARACTERIZATION OF GROUP-SPECIFIC ANTIBODIES GENERATED BY LENTIVIRUSINFECTION OR SUBUNIT IMMUNIZATION IN PRIMATES, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 684-684
INTERNALIZATION OF ANTI-GP120 MONOCLONAL-ANTIBODY AND HUMAN-ANTIBODIES BY HIV-1-INFECTED T-LYMPHOCYTES
Authors: RAKOWICZSZULCZYNSKA E KACZMARSKI W RASO V STEIMER KS DURDA P
Citation: E. Rakowiczszulczynska et al., INTERNALIZATION OF ANTI-GP120 MONOCLONAL-ANTIBODY AND HUMAN-ANTIBODIES BY HIV-1-INFECTED T-LYMPHOCYTES, Antibody immunoconjugates, and radiopharmaceuticals, 6(4), 1993, pp. 209-219
NONAFFINITY PURIFICATION OF RECOMBINANT GP120 FOR USE IN AIDS VACCINEDEVELOPMENT
Authors: SCANDELLA CJ KILPATRICK J LIDSTER W PARKER C MOORE JP MOORE GK MANN KA BROWN P COATES S CHAPMAN B MASIARZ FR STEIMER KS HAIGWOOD NL
Citation: Cj. Scandella et al., NONAFFINITY PURIFICATION OF RECOMBINANT GP120 FOR USE IN AIDS VACCINEDEVELOPMENT, AIDS research and human retroviruses, 9(12), 1993, pp. 1233-1244
Risultati: 1-23 |